PIN1‑silencing mitigates keratinocyte proliferation and the inflammatory response in psoriasis by activating

Shuang Xia1, Jin Li1, Hongshan Yuan1

  • 1Department of Dermatology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu 210001, P.R. China.

PubMed

Insights

Peptidyl-prolyl cis/trans isomerase, NIMA-interacting 1 (PIN1) is elevated in psoriasis. Inhibiting PIN1 reduces skin cell overgrowth and inflammation by enhancing mitochondrial autophagy.

Area of Science:

  • Dermatology
  • Molecular Biology
  • Cell Biology

Background:

  • Peptidyl-prolyl cis/trans isomerase, NIMA-interacting 1 (PIN1) is implicated in skin diseases.
  • The specific role and mechanisms of PIN1 in psoriasis pathogenesis are not well understood.

Purpose of the Study:

  • To investigate the role and molecular mechanism of PIN1 in psoriasis using an in vitro model.
  • To determine the effect of PIN1 inhibition on keratinocyte hyperproliferation, inflammation, and mitochondrial autophagy.

Main Methods:

  • HaCaT cells were stimulated with five cytokines (M5) to mimic psoriatic conditions.
  • PIN1 expression, cell proliferation, inflammatory markers, and mitochondrial autophagy were assessed using RT-qPCR, Western blotting, CCK-8 assay, EdU staining, ELISA, immunofluorescence, and JC-1 assay.
  • The effects of PIN1 silencing and a mitochondrial autophagy inhibitor (Mdivi-1) were evaluated.

Main Results:

  • PIN1 expression was significantly upregulated in M5-induced HaCaT cells.
  • PIN1 silencing suppressed M5-induced keratinocyte hyperproliferation and inflammation while promoting mitochondrial autophagy.
  • Inhibition of mitochondrial autophagy reversed the protective effects of PIN1 interference.

Conclusions:

  • PIN1 is upregulated in psoriatic inflammation-like conditions in HaCaT cells.
  • PIN1 inhibition confers protection against hyperproliferation and inflammatory injury by activating mitochondrial autophagy.
  • Targeting PIN1 may represent a therapeutic strategy for psoriasis.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.4K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K